FDA.reportPublic FDA data

PHENOL

Substance profile for UNII 339NCG44TV, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for PHENOL
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
339NCG44TV
Preferred term
PHENOL
Registry number
108-95-2
EC number
203-632-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C6H6O
Chemical structure for PHENOL
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
ISWSIDIOOBJBQZ-UHFFFAOYSA-N
SMILES
OC1=CC=CC=C1
RxCUI
33290
PubChem
0
NCIt
C1191
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem InChIKey SearchISWSIDIOOBJBQZ-UHFFFAOYSA-Npubchem.ncbi.nlm.nih.gov/#query=ISWSIDIOOBJBQZ-UHFFFAOYSA-N
RxNorm33290mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=33290
NCI ThesaurusC1191ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1191
FDA Substance Registration System339NCG44TVprecision.fda.gov/uniisearch/srs/unii/339NCG44TV
European Community number203-632-7commonchemistry.cas.org/results?q=203-632-7

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTfc36eaa5-499d-4a96-a144-cffae64878a41
ACTIVE MOIETYfc36eaa5-499d-4a96-a144-cffae64878a41
ACTIVE MOIETYChildren's Appetite Enhancer™1
ACTIVE INGREDIENTChildren's Appetite Enhancer™1
ACTIVE MOIETYSORE THROAT SPRAY1
ACTIVE INGREDIENTSORE THROAT SPRAY1
ACTIVE MOIETYRED-KOTE ® WOUND DRESSING2
ACTIVE INGREDIENTRED-KOTE ® WOUND DRESSING2
INACTIVE INGREDIENTCalmodrox Ointment1
INACTIVE INGREDIENTCalasoothe Ointment1
ACTIVE INGREDIENTSmoke Freee1
ACTIVE MOIETYSmoke Freee1
INACTIVE INGREDIENTCalasoothe Ointment1
INACTIVE INGREDIENTPromethazine HCl 12.5 mg Added to 0.9% Sodium Chloride 25 mL Bag4
ACTIVE MOIETYDrug Facts1
ACTIVE INGREDIENTDrug Facts1
ACTIVE MOIETY20079a1d-d99c-48ac-b400-772ce6dd2c653
ACTIVE INGREDIENT20079a1d-d99c-48ac-b400-772ce6dd2c653
INACTIVE INGREDIENTVeraSeptine Multipurpose Moisture Barrier2
INACTIVE INGREDIENTPromethazine HCl 0.625 mg/mL in 0.9% Sodium Chloride 10 mL Syringe1
ACTIVE INGREDIENTCastellani Paint Modified (with color)2
ACTIVE MOIETYCastellani Paint Modified (with color)2
ACTIVE MOIETY01b92e9e-2b1f-41f7-8188-4b15e81aade83
ACTIVE INGREDIENT01b92e9e-2b1f-41f7-8188-4b15e81aade83
ACTIVE MOIETYBetter Breath™1
ACTIVE INGREDIENTBetter Breath™1
ACTIVE INGREDIENT89643c1a-603b-41a1-a185-0468d78bef8c2
ACTIVE MOIETY89643c1a-603b-41a1-a185-0468d78bef8c2
ACTIVE MOIETYfca6cf53-5857-4133-a5f0-73c484046a8f1
ACTIVE INGREDIENTfca6cf53-5857-4133-a5f0-73c484046a8f1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog. NovoLog (insulin aspart [rDNA origin] injection) solution for subcutaneous use Initial U.S. Approval: 2000 ®2
ACTIVE MOIETYDrug Facts1
ACTIVE INGREDIENTDrug Facts1
ACTIVE MOIETYAppetite Enhancer™2
ACTIVE INGREDIENTAppetite Enhancer™2
ACTIVE MOIETYRegency Post-Milking Teat Dip2
ACTIVE INGREDIENTRegency Post-Milking Teat Dip2
ACTIVE MOIETYRegency Pre-Milking Teat Dip2
ACTIVE INGREDIENTRegency Pre-Milking Teat Dip2
ACTIVE INGREDIENTRegency Post-Milking Barrier Teat Dip2
ACTIVE MOIETYRegency Post-Milking Barrier Teat Dip2
ACTIVE MOIETYf643f019-4fdf-4bca-a5f1-7e8b4e1715727
ACTIVE INGREDIENTf643f019-4fdf-4bca-a5f1-7e8b4e1715727
ACTIVE MOIETY9b73e20a-4ac8-4111-a69e-17ee1bca8e651
ACTIVE INGREDIENT9b73e20a-4ac8-4111-a69e-17ee1bca8e651
INACTIVE INGREDIENTBlistex ® Daily Conditioning Treatment1
ACTIVE INGREDIENTDrug Facts2
ACTIVE MOIETYDrug Facts2
ACTIVE MOIETYDrug Facts3
ACTIVE INGREDIENTDrug Facts3
ACTIVE INGREDIENTDrug Facts2
ACTIVE MOIETYDrug Facts2
INACTIVE INGREDIENTNovolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) ®2
INACTIVE INGREDIENTNovolin N NPH, Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL2
ACTIVE INGREDIENTDrug Facts1
ACTIVE MOIETYDrug Facts1
ACTIVE MOIETY5ab588e5-c2de-4077-a629-91a762f86af51
ACTIVE INGREDIENT5ab588e5-c2de-4077-a629-91a762f86af51
ACTIVE INGREDIENTc4f89120-4ce8-42df-9626-0437815ac2061
ACTIVE MOIETYc4f89120-4ce8-42df-9626-0437815ac2061
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTDrug Facts1
ACTIVE INGREDIENTAllergyEase Scent and Phenol1
ACTIVE MOIETYAllergyEase Scent and Phenol1
ACTIVE INGREDIENTDrug Facts1
ACTIVE MOIETYDrug Facts1
ACTIVE MOIETYDrug Facts1
ACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog. NovoLog ® (insulin aspart [rDNA origin] injection) solution for subcutaneous use Initial U.S. Approval: 20001
ACTIVE MOIETY40159073-39ca-4557-8478-8490fb6986ea1
ACTIVE INGREDIENT40159073-39ca-4557-8478-8490fb6986ea1
INACTIVE INGREDIENTTuberculin Purified Protein Derivative (Mantoux) TUBERSOL ®1
ACTIVE MOIETYDigestive Upsets Natural Pet Pharmaceuticals1
ACTIVE INGREDIENTDigestive Upsets Natural Pet Pharmaceuticals1
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL1
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL1
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL2
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL4
ACTIVE INGREDIENTDrug Facts1
ACTIVE MOIETYDrug Facts1
ACTIVE INGREDIENT1b5d1614-4a4c-41d9-b9c1-733592695f143
ACTIVE MOIETY1b5d1614-4a4c-41d9-b9c1-733592695f143
INACTIVE INGREDIENT0407a732-95b8-42b4-a21d-f42cfe9938532
ACTIVE MOIETYa19f01c2-ca3f-4499-9ebc-047371ce8a7e1
ACTIVE INGREDIENTa19f01c2-ca3f-4499-9ebc-047371ce8a7e1
ACTIVE INGREDIENTRED-KOTE ® VETERINARY SCARLET RED OIL3
ACTIVE MOIETYRED-KOTE ® VETERINARY SCARLET RED OIL3
ACTIVE INGREDIENTChapStick Medicated (camphor, menthol, petrolatum, and phenol)5
ACTIVE MOIETYChapStick Medicated (camphor, menthol, petrolatum, and phenol)5
ACTIVE INGREDIENTDRUG FACTS2
ACTIVE MOIETYDRUG FACTS2
INACTIVE INGREDIENTOctreotide Acetate Injection1
INACTIVE INGREDIENTOctreotide Acetate Injection1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 19962
ACTIVE MOIETYChildren's Appetite Enhancer1
ACTIVE INGREDIENTChildren's Appetite Enhancer1
ACTIVE MOIETYDrug Facts3
ACTIVE INGREDIENTDrug Facts3
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL3
ACTIVE INGREDIENTFoul Bowel3
ACTIVE MOIETYFoul Bowel3
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL2
ACTIVE MOIETYAppetite Enhancer1
ACTIVE INGREDIENTAppetite Enhancer1
ACTIVE INGREDIENTFungus Fighter2
ACTIVE MOIETYFungus Fighter2
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTDrug Facts1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 19963
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL1
INACTIVE INGREDIENTDrug Facts1
ACTIVE INGREDIENTDrug Facts1
ACTIVE MOIETYDrug Facts1
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL1
INACTIVE INGREDIENTThese highlights do not include all the information needed to use LEVEMIR ® safely and effectively. See full prescribing information for LEVEMIR. LEVEMIR ® (insulin detemir [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 20052
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL1
INACTIVE INGREDIENTNovolin ® 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)2
INACTIVE INGREDIENTALLERGENIC EXTRACTS INDIVIDUAL TREATMENT VIAL1
ACTIVE MOIETYSmoke Control4

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 339NCG44TV page 1 of 1 · 19 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
PHENOL339NCG44TV108952INJECTIONINTRA-ARTICULAR0.5 %w/v
PHENOL339NCG44TV108952INJECTIONINTRADERMAL0.25 %w/v
PHENOL339NCG44TV108952INJECTIONINTRALESIONAL0.5 %w/v
PHENOL339NCG44TV108952INJECTIONINTRAMUSCULAR48 mg
PHENOL339NCG44TV108952INJECTION, POWDER, FOR SOLUTIONINTRAMUSCULAR2 mg
PHENOL339NCG44TV108952INJECTION, SOLUTIONINTRAMUSCULAR75 mg
PHENOL339NCG44TV108952INJECTIONINTRASYNOVIAL0.5 %w/v
PHENOL339NCG44TV108952INJECTIONINTRAVENOUS48 mg
PHENOL339NCG44TV108952INJECTION, POWDER, FOR SOLUTIONINTRAVENOUS2 mg
PHENOL339NCG44TV108952INJECTION, SOLUTIONINTRAVENOUS75 mg
PHENOL339NCG44TV108952LIQUIDINTRAVENOUS0.5 %w/v
PHENOL339NCG44TV108952SOLUTIONINTRAVENOUS23 mg
PHENOL339NCG44TV108952DROPSOPHTHALMIC0.01 %w/w
PHENOL339NCG44TV108952INJECTIONSUBCUTANEOUS48 mg
PHENOL339NCG44TV108952INJECTION, POWDER, FOR SOLUTIONSUBCUTANEOUS2 mg
PHENOL339NCG44TV108952INJECTION, SOLUTIONSUBCUTANEOUS0.55 %w/v
PHENOL339NCG44TV108952INJECTION, SUSPENSIONSUBCUTANEOUS0.07 %w/v
PHENOL339NCG44TV108952LIQUIDSUBCUTANEOUS0.5 %w/v
PHENOL339NCG44TV108952DOUCHEVAGINAL0.14 %w/w